|
IDE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.230030E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.241100E-03 |
| Normal-vs-Stage2 |
5.635800E-01 |
| Normal-vs-Stage3 |
3.395000E-01 |
| Normal-vs-Stage4 |
2.744000E-01 |
| Stage1-vs-Stage2 |
3.796000E-01 |
| Stage1-vs-Stage3 |
4.235000E-01 |
| Stage1-vs-Stage4 |
9.903600E-01 |
| Stage2-vs-Stage3 |
8.660200E-01 |
| Stage2-vs-Stage4 |
5.655600E-01 |
| Stage3-vs-Stage4 |
6.096200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.560800E-03 |
| Normal-vs-AfricanAmerican |
2.096600E-01 |
| Normal-vs-Asian |
6.447800E-02 |
| Caucasian-vs-AfricanAmerican |
4.277600E-01 |
| Caucasian-vs-Asian |
8.274800E-01 |
| AfricanAmerican-vs-Asian |
3.681600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.42950000000275E-05 |
| Normal-vs-Female |
1.430200E-01 |
| Male-vs-Female |
1.58716999999475E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.573050E-01 |
| Normal-vs-Extreme_Weight |
2.5763000000012E-06 |
| Normal-vs-Obese |
1.779420E-01 |
| Normal-vs-Extreme_Obese |
8.490300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.167760E-01 |
| Normal_Weight-vs-Obese |
6.716800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.017600E-01 |
| Extreme_Weight-vs-Obese |
4.240000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.527000E-01 |
| Obese-vs-Extreme_Obese |
3.377200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.553800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.341850E-01 |
| Normal-vs-Age(61-80Yrs) |
3.356900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.367810E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.697000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.064800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.267600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.627210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.898800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.191600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.627000E-04 |
| Normal-VS-Type2 PRCC |
1.899560E-01 |
| Normal-VS-KIRP CIMP |
3.480200E-01 |
| Normal-VS-Unclassified PRCC |
7.761000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.012300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.316700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.077800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.417200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.426000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.142200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.025620E-02 |
| Normal-vs-N1 |
8.494400E-01 |
| Normal-vs-N2 |
9.522200E-01 |
| N0-vs-N1 |
1.118230E-01 |
| N0-vs-N2 |
4.551200E-01 |
| N1-vs-N2 |
9.976200E-01 |
|
|
